Biogen Pharmachem Industries Limited

Key Financial Figures

  • Total Income: ₹255.80 lakh (comprising other income only)
  • Net Expenses: ₹160.13 lakh
  • Employee Benefit Expense: ₹28.28 lakh
  • Other Expenses: ₹131.85 lakh (including annual custody fees ₹36.13 lakh, balance written off ₹63.84 lakh, stamp duty ₹12.96 lakh)
  • Profit Before Tax: ₹95.67 lakh
  • Tax Expense: ₹9.73 lakh (current tax)
  • Net Profit for the Year: ₹85.95 lakh
  • Earnings Per Share (Basic & Diluted): ₹0.01

Capital Structure Impact

  • Authorized Capital: ₹9,100.00 lakh (91,00,00,000 equity shares of ₹1 each)
  • Issued, Subscribed & Paid-up Capital: Increased from ₹6,526.03 lakh (65,26,03,000 shares) to ₹9,026.03 lakh (90,26,03,000 shares)
  • Increase Due To: Allotment of 25,00,00,000 equity shares on conversion of fully convertible warrants issued on preferential basis to non-promoter group on 15.04.2025
  • Security Premium: ₹1,700.00 lakh (previous year: nil)
  • Money Received Against Share Warrants: ₹3,570.00 lakh (previous year), fully converted during current year

Significant Balances (as at 31.03.2026)

  • Investments: ₹3,278.23 lakh (including quoted equity shares ₹2,372.71 lakh, unquoted equity shares ₹34.00 lakh, partnership firm investment ₹871.51 lakh)
  • Loans Given: ₹6,612.97 lakh (unsecured, considered good)
  • Cash & Cash Equivalents: ₹32.16 lakh
  • Other Financial Assets: ₹16.53 lakh (TDS receivable)
  • Other Current Liabilities: ₹31.18 lakh (including tax provision ₹9.73 lakh)

Corporate Governance & Board Details

Board of Directors:

  • Chandrakant Govindbhai Parmar (Director)
  • Kelash Bunkar (Whole-time Director & CFO)
  • Chhayaben Parmar (Director)
  • Narendrakumar Vaniya (Director)
  • Aman Patel (Director)
  • Harshadkumar Rathod (Director)

Key Managerial Personnel:

  • Kelash Bunkar (Whole-time Director & CFO)
  • Khushboo Khandelwal (Company Secretary)

Auditor: M/s. Goenka Mehta & Associates, Chartered Accountants, Rajkot (Firm Registration No: 129445W)

Share Transfer Agent: M/s Satellite Corporate Services Private Limited, Mumbai

AGM Details

  • Date: Tuesday, 29th September 2026 at 04:00 PM
  • Mode: Video Conferencing/Other Audio Visual Means
  • Business:

1. Adoption of audited financial statements

2. Re-appointment of Mr. Kelash Bunkar (DIN: 10911360) who retires by rotation

3. Re-appointment of statutory auditors M/s. Goenka Mehta & Associates for 5 years

Regulatory Compliance Matters

  • Secretarial Audit Qualifications:
  • Non-compliance with certain SEBI LODR regulations regarding publication of notices and quarterly results
  • Non-appointment of Internal Auditor as required under Section 138 of Companies Act, 2013
  • Income Tax Dispute: ₹303.10 lakh pending with ITAT
  • Book Closure: 22nd September 2026 to 29th September 2026 (both days inclusive)

Operational Review

  • Company engaged in trading of shares and securities
  • No significant business activities due to scarcity of working capital funds
  • No manufacturing activities conducted
  • No subsidiaries, joint ventures or associate companies
  • No deposits accepted within meaning of Section 73 of Companies Act, 2013

Other Disclosures

  • No dividend recommended for the year
  • No amount transferred to reserves
  • No material related party transactions
  • No material changes affecting financial position post year-end
  • No significant orders passed by regulators/courts impacting going concern
  • No fraud reported by auditors
  • No sexual harassment complaints received
  • Pending income tax dispute of ₹303.10 lakh with ITAT

Cash Flow Implications

  • Net Cash from Operating Activities: ₹156.83 lakh
  • Net Cash used in Investing Activities: ₹956.29 lakh (mainly investments ₹893.82 lakh, increase in loans ₹62.47 lakh)
  • Net Cash from Financing Activities: ₹630.00 lakh (from preferential warrants)
  • Net Decrease in Cash: ₹169.46 lakh